A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients
- 15 May 2009
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (10), 3633-3639
- https://doi.org/10.1158/1078-0432.ccr-09-0017
Abstract
Purpose: It has recently been shown that it is possible to improve the prediction of carboplatin clearance by adding plasma cystatin C level (cysC), an endogenous marker of glomerular filtration rate, to the other patient characteristics routinely used for carboplatin individual dosing, namely serum creatinine (Scr), actual body weight (ABW), age, and sex. This multicenter pharmacokinetic study was done to evaluate prospectively the benefit of using cysC for carboplatin individual dosing. Experimental Design: The 357 patients included in the study were receiving carboplatin as part of established protocols. A population pharmacokinetic analysis was done using NONMEM program. Seven covariates studied were as follows: Scr, cysC, age, sex, ABW, ideal body weight, and lean body mass. Results: The best covariate equation was as follows: carboplatin clearance (mL/min) = 117.8. (Scr/75)−0.450. (cysC/1,00)−0.385. (ABW/65)+0.504. (age/56)−0.366. 0.847sex, with Scr in μmol/L, cysC in mg/L, ABW in kilograms, age in years, and sex = 0 for male. Using an alternative weight descriptor (ideal body weight or lean body mass) did not improve the prediction. This final covariate model was validated by bootstrap analysis. The bias (mean percentage error) and imprecision (mean absolute percentage error) were +1% and 15%, respectively, on the total population, and were of a similar magnitude in each of the three subgroups of patients defined according to their body mass index. Conclusion: For the first time, a unique formula is proposed for carboplatin individual dosing to patients, which is shown to be equally valid for underweight, normal weight, and obese patients.Keywords
This publication has 19 references indexed in Scilit:
- Comparing Measures of Cystatin C in Human Sera by Three MethodsAmerican Journal of Nephrology, 2008
- Flat Dosing of Carboplatin Is Justified in Adult Patients with Normal Renal FunctionClinical Cancer Research, 2006
- Serum Cystatin C for the Prediction of Glomerular Filtration Rate With Regard to the Dose Adjustment of Amikacin, Gentamicin, Tobramycin, and VancomycinTherapeutic Drug Monitoring, 2006
- Serum Cystatin C is a Better Marker of Topotecan Clearance than Serum CreatinineClinical Cancer Research, 2005
- Cystatin C as a New Covariate to Predict Renal Elimination of DrugsClinical Pharmacokinetics, 2005
- Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing: a prospective studyEuropean Journal Of Cancer, 2002
- Clinical Pharmacokinetics and Dose Optimisation of CarboplatinClinical Pharmacokinetics, 1997
- Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient CharacteristicsJNCI Journal of the National Cancer Institute, 1995
- Analysis of platinum in biological materials by flameless atomic absorption spectrophotometryBiochemical Medicine, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976